(1)
Correa-González, N. F.; Díaz-Cortés, D.; Muñoz Velandia, O. M. Intravenous Immunoglobulin Costs Are Higher for off-Label Indications in a High-Complexity Hospital in Colombia. Univ. Med. 2024, 64.